Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.
Colorectal cancer screening
faecal haemoglobin
faecal immunochemical test
sex differences
Journal
Journal of medical screening
ISSN: 1475-5793
Titre abrégé: J Med Screen
Pays: England
ID NLM: 9433359
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
7
11
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
ppublish
Résumé
This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer. Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National Health Service Board, socioeconomic status, and screening history. Linkage with The Scottish Cancer Registry identified all screening participants diagnosed with colorectal cancer. Logistic regression was performed to identify which factors demonstrated significant association with colorectal cancer and could be used in the development of a risk-scoring model. Of 232,076 screening participants, 427 had colorectal cancer: 286 diagnosed following a screening colonoscopy and 141 arising after a negative screening test result giving an interval cancer proportion of 33.0%. Only faecal haemoglobin concentration and age showed a statistically significant association with colorectal cancer. Interval cancer proportion increased with age and was higher in women (38.1%) than men (27.5%). If positivity in women were mirrored in men at each age quintile interval cancer proportion would still have remained higher in women (33.2%). Moreover, an additional 1201 colonoscopies would be required to detect 11 colorectal cancers. Development of a risk scoring model using early data from the Scottish Bowel Screening Programme was not feasible due to most variables showing insignificant association with colorectal cancer. Tailoring the faecal haemoglobin concentration threshold according to age could help to diminish some of the disparity in interval cancer proportion between women and men. Strategies to achieve sex equality using faecal haemoglobin concentration thresholds depend considerably on which variable is selected for equivalency and this requires further exploration.
Identifiants
pubmed: 37229658
doi: 10.1177/09691413231175611
pmc: PMC10629250
doi:
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
184-190Déclaration de conflit d'intérêts
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Am J Gastroenterol. 2008 Jun;103(6):1541-9
pubmed: 18479499
Br J Cancer. 2018 Jan;118(2):285-293
pubmed: 29096402
Dig Dis Sci. 2015 Mar;60(3):609-22
pubmed: 25492500
Clin Chem Lab Med. 2022 Jul 13;60(10):1496-1505
pubmed: 35848100
Clin Chem Lab Med. 2020 Nov 26;58(12):2073-2080
pubmed: 32324157
Clin Chem Lab Med. 2022 Jun 01;60(8):1278-1286
pubmed: 35637625
Colorectal Dis. 2018 Sep;20(9):O277-O283
pubmed: 29863812
BMJ Open. 2021 Feb 8;11(2):e046667
pubmed: 33558363
J Med Screen. 2014 Jun;21(2):95-7
pubmed: 24803480
BMC Cancer. 2018 Sep 20;18(1):906
pubmed: 30236083
J Med Screen. 2021 Dec;28(4):439-447
pubmed: 34106777
Br J Cancer. 2022 Apr;126(7):1091-1099
pubmed: 35022524
Int J Cancer. 2023 Apr 15;152(8):1536-1546
pubmed: 36444504
United European Gastroenterol J. 2013 Jun;1(3):198-205
pubmed: 24917960
Clin Chem Lab Med. 2011 Dec 07;50(5):935-40
pubmed: 22149740
Br J Cancer. 2022 May;126(8):1229-1235
pubmed: 35058592
Prev Med. 2022 Apr;157:106990
pubmed: 35150749
Prev Med Rep. 2021 Jun 09;23:101447
pubmed: 34168954
J Med Screen. 2022 Mar;29(1):26-31
pubmed: 34806935
Gastrointest Endosc. 2022 Mar;95(3):540-549
pubmed: 34626590
Ann Clin Biochem. 2022 Nov;59(6):450-452
pubmed: 36031942
Br J Cancer. 2012 Jul 24;107(3):417-21
pubmed: 22782347
Clin Endosc. 2017 May;50(3):254-260
pubmed: 28320200
Int J Cancer. 2019 Aug 1;145(3):728-734
pubmed: 30694563
Gut. 2017 Sep;66(9):1631-1644
pubmed: 27267903
Gut. 2023 Jan;72(1):101-108
pubmed: 35537811
Gut. 2012 Apr;61(4):576-81
pubmed: 21930729